黃善敏醫生 - 臨床腫瘤科
臨床腫瘤科專科醫生
重點資料
- 醫務委員會註冊已驗證
- 臨床腫瘤科專科醫生香港大學內外全科醫學士 · 香港放射科醫學院院士 · 2012 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
黃善敏醫生是香港註冊的臨床腫瘤科專科醫生。
學歷
保險計劃
常見問題
黃善敏醫生好嗎？
黃善敏醫生是香港註冊的臨床腫瘤科專科醫生。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
黃善敏醫生是做什麼的？
黃善敏醫生是臨床腫瘤科醫生。
研究及論文
共 12 篇
按論文主題篩選
主題由同一批 PubMed 論文的醫學分類整理，不代表醫生提供相關診治服務。
- Compensatory Hypertrophy and Changes of Liver Function After Sequential Transarterial Chemoembolization, Stereotactic Body Radiation Therapy, and Immunotherapy (START-FIT) in Unresectable Hepatocellular Carcinoma.International journal of radiation oncology, biology, physics · 2026
- Early Outcomes of Preoperative Short Course Radiotherapy With Simultaneous Integrated Boost and Response-adapted Chemotherapy for Advanced Rectal Cancer.Clinical oncology (Royal College of Radiologists (Great Britain)) · 2025
- Long-Term Outcome of Stereotactically Designed Hypofractionated Image Guided Radiation Therapy in Large, Unresectable Hepatocellular Carcinoma.Practical radiation oncology · 2025
- Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma.JAMA oncology · 2024
- Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma.Liver cancer · 2024
- Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial.The lancet. Gastroenterology & hepatology · 2023
- Neoadjuvant short-course radiotherapy or chemoradiation plus consolidative chemotherapy followed by radical operation for locally advanced rectal cancer.Frontiers in oncology · 2023
- Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer.Frontiers in oncology · 2023
- Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong Experience.Frontiers in oncology · 2022
- Presence of tumour capsule on contrast-enhanced CT is associated with improved outcomes of stereotactic body radiation therapy in hepatocellular carcinoma patients.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2022
- Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience.Frontiers in oncology · 2022
- Palliative Liver Radiotherapy (RT) for Symptomatic Hepatocellular Carcinoma (HCC).Scientific reports · 2020
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明